These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25580783)

  • 1. Epidemiology of autoimmune bullous diseases and therapeutic modalities during a 10 year period in Iran.
    Jowkar F; Sadati MS; Tavana S; Agah MA
    Acta Dermatovenerol Croat; 2014; 22(4):246-9. PubMed ID: 25580783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spectrum of autoimmune bullous diseases in Iran: a 10-year review.
    Daneshpazhooh M; Chams-Davatchi C; Payandemehr P; Nassiri S; Valikhani M; Safai-Naraghi Z
    Int J Dermatol; 2012 Jan; 51(1):35-41. PubMed ID: 22182376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spectrum of Autoimmune Bullous Diseases in Northern Greece. A 4-year Retrospective Study and Review of the Literature.
    Patsatsi A; Lamprou F; Kokolios M; Stylianidou D; Trigoni A; Kalampalikis D; Sotiriadis D
    Acta Dermatovenerol Croat; 2017 Oct; 25(3):195-201. PubMed ID: 29252171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of autoimmune bullous diseases in Middle Franconia.
    Sollfrank L; Schönfelder V; Sticherling M
    Front Immunol; 2023; 14():1256617. PubMed ID: 37881435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study.
    Ghiasi M; Daneshpazhooh M; Ismonov M; Chams-Davatchi C
    Skinmed; 2017; 15(3):175-180. PubMed ID: 28705276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The burden of neurological comorbidities in six autoimmune bullous diseases: a population-based study.
    Kridin K; Hübner F; Recke A; Linder R; Schmidt E
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2074-2078. PubMed ID: 34153122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal Autoimmune Blistering Disease: A Systematic Review.
    Zhao CY; Chiang YZ; Murrell DF
    Pediatr Dermatol; 2016 Jul; 33(4):367-74. PubMed ID: 27086740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association of six autoimmune bullous diseases with thyroid disorders: a population-based study.
    Kridin K; Hübner F; Linder R; Schmidt E
    J Eur Acad Dermatol Venereol; 2022 Oct; 36(10):1826-1830. PubMed ID: 35611551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-linked immunosorbent assay in autoimmune blistering diseases: preliminary experience of the Dermatology Department of Cagliari.
    Atzori L; Deidda S; Aste N
    G Ital Dermatol Venereol; 2008 Feb; 143(1):1-8. PubMed ID: 18833046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrum of autoimmune bullous diseases in Kuwait.
    Nanda A; Dvorak R; Al-Saeed K; Al-Sabah H; Alsaleh QA
    Int J Dermatol; 2004 Dec; 43(12):876-81. PubMed ID: 15569006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
    Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
    Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany.
    Bertram F; Bröcker EB; Zillikens D; Schmidt E
    J Dtsch Dermatol Ges; 2009 May; 7(5):434-40. PubMed ID: 19170813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Successful treatment of autoimmune bullous diseases with a combination therapy of ciclosporin and corticosteroid].
    Kato H; Murata S; Suzuki M; Yaoita H
    Nihon Hifuka Gakkai Zasshi; 1989 Jan; 99(1):53-7. PubMed ID: 2664289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A survey of bullous diseases in a Turkish university hospital: clinicoepidemiological characteristics and follow-up.
    Kutlubay Z; Sevim Keçici A; Çelik U; Mat MC
    Turk J Med Sci; 2021 Feb; 51(1):124-133. PubMed ID: 32892539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective Study on Autoimmune Blistering Disease in Paediatric Patients.
    Kong YL; Lim YL; Chandran NS
    Pediatr Dermatol; 2015; 32(6):845-52. PubMed ID: 26391853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group.
    Bernard P; Vaillant L; Labeille B; Bedane C; Arbeille B; Denoeux JP; Lorette G; Bonnetblanc JM; Prost C
    Arch Dermatol; 1995 Jan; 131(1):48-52. PubMed ID: 7826096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spectrum of subepidermal immunobullous disorders seen at the National Skin Centre, Singapore: a 2-year review.
    Wong SN; Chua SH
    Br J Dermatol; 2002 Sep; 147(3):476-80. PubMed ID: 12207586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of refractory blistering autoimmune diseases with mycophenolic acid.
    Marzano AV; Dassoni F; Caputo R
    J Dermatolog Treat; 2006; 17(6):370-6. PubMed ID: 17853312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Item 116--Autoimmune bullous dermatoses].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A94-101. PubMed ID: 23176869
    [No Abstract]   [Full Text] [Related]  

  • 20. High-dose intravenous immune globulin for the treatment of autoimmune blistering diseases: an evaluation of its use in 14 cases.
    Harman KE; Black MM
    Br J Dermatol; 1999 May; 140(5):865-74. PubMed ID: 10354024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.